A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Clinical trial NCT02452424 · TERMINATED

Trial details

NCT number: NCT02452424
Sponsor: Daiichi Sankyo
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Non-small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck Gastrointestinal Stromal Tumor (GIST)Ovarian Cancer

Start date: 2015-07-02
Primary completion: 2018-08-17
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.